Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 8:48 p.m.

    📋 Lyra Therapeutics Inc (LYRA) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 07:30:26

    Event Type: Clinical Trial Update

    Event Details:

    Lyra Therapeutics Inc (LYRA) Announces Clinical Trial Update Lyra Therapeutics Inc (LYRA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Registrant’s Telephone Number, Including Area Code

    🔬 Clinical Development Pipeline (Lyra Therapeutics Inc):

    Product Type Development Stage Therapeutic Area Source
    480 Mometasone Furoate Sinus Drug Depot DRUG Phase PHASE1 Chronic Sinusitis ClinicalTrials.gov
    LYR-210 DRUG Phase PHASE2 Chronic Sinusitis ClinicalTrials.gov
    TDM-105795 topical vehicle solution DRUG Phase PHASE2 Alopecia, Androgenetic ClinicalTrials.gov
    TDM-105795, 0.02% DRUG Phase PHASE2 Alopecia, Androgenetic ClinicalTrials.gov
    TDM-105795, 0.0025% DRUG Phase PHASE2 Alopecia, Androgenetic ClinicalTrials.gov
    Placecbo DRUG Phase PHASE2 Restless Leg Syndrome ClinicalTrials.gov
    BRC-002 DRUG Phase PHASE2 Restless Leg Syndrome ClinicalTrials.gov
    Sham comparator OTHER Phase PHASE2 Chronic Sinusitis ClinicalTrials.gov
    Bilateral sham procedure control (Part 2) DRUG Phase PHASE2 Chronic Sinusitis ClinicalTrials.gov
    LYR-220 Design 2 (Part 1 and Part 2) DRUG Phase PHASE2 Chronic Sinusitis ClinicalTrials.gov
    LYR-220 Design 1 (Part 1 only) DRUG Phase PHASE2 Chronic Sinusitis ClinicalTrials.gov
    Background therapy OTHER Phase PHASE3 Chronic Sinusitis ClinicalTrials.gov
    Sham procedure control DRUG Phase PHASE3 Chronic Sinusitis ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes

    Structured Data:

    • Company Name: Lyra Therapeutics Inc
    • Ticker Symbol: LYRA

Search

News categories